Abbott launches Xience Prime in Europe, other international markets

Justine Varieur Cadet | | Cardiovascular Business | Interventional Cardiology
Abbott has launched its Xience Prime everolimus-eluting coronary stent system for the treatment of coronary artery disease at the European Society of Cardiology (ESC) Congress this week in Barcelona, Spain. 

Xience Prime, which received CE Mark approval in June, is now available in Europe, and in select countries in Asia-Pacific and Latin America.

According to the Abbott Park, Ill.-based company, Xience Prime utilizes the same drug and biocompatible polymer as its Xience V everolimus-eluting coronary stent system. The new drug-eluting stent also is based on the design used in the Multi-Link Vision family of stents. Xience Prime uses cobalt chromium technology. Xience Prime is available in a various size matrix, including Xience Prime SV for small vessels and Xience Prime LL for long lesions.

Xience Prime currently is an investigational device in the United States and is not available for sale in that country.

Justine Varieur Cadet

Related Content

Cardiologists reflect on developing primary PCI in face of criticism and pushback
How TAVR valve choice impacts outcomes when treating type 1 bicuspid AS
IVUS-guided PCI reduces risks in patients with diabetes
Medtronic using AI to identify more TAVR patients in need
SAVR linked to higher 10-year survival rate than TAVR for low-risk patients
LAAC with Watchman FLX reduces bleeding risks after AFib ablation

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."